Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med. 1997;337:1569 75. S7.1.1.2-5. Vakil K, Florea V, Koene R, et al. Effect of coronary artery bypass grafting on left ventricular ejection fraction in men eli- gible for implantable cardioverter-defibrillator. Am J Cardiol. 2016;117:957 60. S7.1.1.2-6. Mittal S, Lomnitz DJ, Mirchandani S, et al. Prognostic significance of nonsustained ventricular tachycardia after revascularization. J Cardiovasc Electrophysiol. 2002;13:342 6. S7.1.1.2-7. Zishiri ET, Williams S, Cronin EM, et al. Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defi- brillator. Circ Arrhythm Electrophysiol. 2013;6:117 28. 7.1.2. Primary Prevention of SCD in Patients With Ischemic Heart Disease S7.1.2-1. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225 37. S7.1.2-2. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877 83. S7.1.2-3. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996;335:1933 40. S7.1.2-4. Owens DK, Sanders GD, Heidenreich PA, et al. Effect of risk strati- fication on cost-effectiveness of the implantable cardioverter defi- brillator. Am Heart J. 2002;144:440 8. S7.1.2-5. Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the pre- vention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 1999;341:1882 90. S7.1.2-6. Cantero-P rez EM, Sobrino-M rquez JM, Grande-Trillo A, et al. Implantable cardioverter defibrillator for primary prevention in patients with severe ventricular dysfunction awaiting heart trans- plantation. Transplant Proc. 